Zhengye Biotechnology regains Nasdaq compliance with $1 minimum bid price rulePUBT·Aug 6 at 07:01 AMZYBT+1.96%
The Unbundling of the Value Chain: From Physical Infrastructure to Digital AggregatorsGlobal Report·Aug 4 at 04:17 AMCDP-0.89%SBET-0.95%
Regulatory Divergence Drives Biotech Revaluation: Key Signals from Six DrugmakersGlobal Report·Aug 2 at 04:13 AMDRTS-1.72%CPHI+3.67%
Biotech's 2026 Reality Check: Who's Actually Delivering Beyond the Hype?Global Report·Aug 1 at 04:14 AMIBRX-1.05%ABCL+3.74%
The Wall Street Basement: A Survival Guide to 10 Micro-Cap MisfitsGlobal Report·Jul 31 at 04:23 AMLAB-4.99%ZYBT+1.96%
Broad Divergence: Coupang Enters Fortune 500 While Mid-Cap Firms Face Nasdaq Compliance HeadwindsGlobal Report·Jul 30 at 04:13 AMSATL-1.53%CPNG-1.04%
Mid-2026 Corporate Shifts: EQT Raises Output Guidance as Kimberly-Clark Advances USD 48.7B DealGlobal Report·Jul 29 at 04:18 AMAVTR-1.37%CBOE+1.04%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jul 23 at 12:05 PMNUWE+0.77%ZYBT+1.96%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 07:06 AMSXTC+31.21%HYFT+1.44%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jul 22 at 04:05 PMZYBT+1.96%CYH+1.01%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 22 at 12:05 PMCPHI+3.67%PMI+0.57%
Zhengye Biotechnology Stock Plunges Following 322% Rally In Volatile Reversalbenzinga_article·Jul 22 at 10:59 AMZYBT+1.96%
